Farmers & Merch Banc (FMAO) 31.1000 $FMAO OTCQX Dividend

New Post Public Reply Private Reply Replies (0) Message Board

Aug 22, 2016 at 1:11 PM

Farmers & Merch Banc (FMAO) 31.1000 $FMAO

OTCQX Dividend Index Launches
PR Newswire - Thu Jun 02, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of the OTCQX®, OTCQB® and Pink® markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Dividend Index (.OTCQXDIV), a new benchmark for tracking the performance of US and International Companies trading on the OTCQX Market that pay a regular dividend.

Farmers & Merchants State Bank Announces its 24th Branch Office in Bowling Green, Ohio
GlobeNewswire - Wed May 11, 2:27PM CDT
Paul S. Siebenmorgen, President and CEO of Farmers & Merchants State Bank in Archbold, Ohio, is pleased to announce the selection of the bank's 24th full-service office, in Bowling Green, Ohio. The new office is scheduled to open this summer.

Farmers & Merchants Bancorp, Inc. Reports 2016 First-Quarter Financial Results
PR Newswire - Wed Apr 20, 9:00AM CDT
Farmers & Merchants Bancorp, Inc. (OTCQX: FMAO) today reported financial results for the 2016 first quarter ended March 31, 2016.

Farmers & Merchants Bancorp, Inc. Declares 2016 First Quarter Dividend
PR Newswire - Fri Mar 18, 9:30AM CDT
The Board of Directors of Farmers & Merchants Bancorp, Inc., (OTCQX: FMAO) the holding company of The Farmers & Merchants State Bank, with assets of approximately $989 million at December 31, 2015, declared the 2016 first quarter cash dividend of $0.22 per share. The first quarter dividend is payable on April 20, 2016 to shareholders of record as of March 29, 2016.

Farmers & Merchants Bancorp reports 4.2% increase in net income for Q4 2015
M2 - Fri Feb 05, 3:08AM CST
Farmers & Merchants Bancorp Inc (OTCQX:FMAO) on Thursday reported for the 2015 fourth quarter ended 31 December 2015 a net income of USD2.8m or USD0.60 per basic and diluted share, a 4.2% improvement compared to the net income of USD2.7m or USD0.57 per basic and diluted share for the same period last year.

Farmers & Merchants Bancorp, Inc. Reports 2015 Fourth-Quarter and Full-Year Financial Results
PR Newswire - Thu Feb 04, 7:15AM CST
Farmers & Merchants Bancorp, Inc. (OTCQX: FMAO) today reported financial results for the 2015 fourth quarter and twelve months ended December 31, 2015.

Farmers & Merchants Bancorp, Inc. to Webcast, Live, at OTCQX Banks Virtual Investor Conference February 4
PR Newswire - Fri Jan 29, 7:26AM CST
Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual conference at VirtualInvestorConferences.com

OTC Markets Group Announces Agenda for February 4th OTCQX Banks Virtual Investor Conference
PR Newswire - Thu Jan 28, 3:22PM CST
Individual and institutional investors invited to log on and ask questions directly to bank CEOs and their senior executives

Farmers & Merchants Bancorp declares Q4 2015 dividend
M2 - Mon Dec 28, 6:45AM CST
Board of directors of Farmers & Merchants Bancorp, Inc., (OTCQX: FMAO), holding company of The Farmers & Merchants State Bank with assets of approximately USD960 million, has declared a fourth quarter dividend of USD0.22 per share. The fourth quarter dividend is payable on January 20, 2016 to shareholders of record date as of December 29, 2015. The Farmers & Merchants State Bank is a local independent community bank serving Northwest Ohio and Northeast Indiana with commercial banking, retail banking and other financial services through its 22 offices.

Farmers & Merchants Bancorp announces Q4 2015 dividend of USD0.22 per share
M2 - Mon Dec 21, 7:03AM CST
Farmers & Merchants Bancorp Inc's (OTCQX:FMAO) board of directors authorised a dividend of USD0.22 per share for the fourth quarter, the company reported on Friday.

Farmers & Merchants Bancorp Reports 2015 Third-Quarter and Nine Month Financial Results
PR Newswire - Wed Oct 28, 1:27PM CDT
Farmers & Merchants Bancorp, Inc. (OTCQX: FMAO) today reported financial results for the 2015 third quarter and nine months ended September 30, 2015.

Farmers & Merchants Bancorp, Inc. Declares 3rd Quarter Dividend
PR Newswire - Fri Sep 18, 10:38AM CDT
The Board of Directors of Farmers & Merchants Bancorp, Inc., (OTCQX: FMAO) the holding company of The Farmers & Merchants State Bank, with assets of approximately $950 million, at their regular meeting on Friday, September 18, 2015 declared a third quarter dividend of twenty-two cents ($0.22) per share. The third quarter dividend is payable on October 20, 2015 to shareholders of record date as of September 29, 2015.

Orrstown Financial Services (ORRF) Jumps: Stock Up 6.3%
Zacks Equity Research - Zacks Investment Research - Wed Sep 16, 7:30AM CDT
Orrstown Financial Services Inc. (ORRF) was a big mover last session, as the company saw its shares rise over 6% on the day.
ORRF: 19.91 (-0.02)

Territorial Bancorp Up to Strong Buy on Solid Q2 Earnings
Zacks Equity Research - Zacks Investment Research - Fri Aug 14, 4:00PM CDT
On Aug 13, 2015, Zacks Investment Research upgraded Territorial Bancorp Inc. (TBNK) a notch higher to a Zacks Rank #1 (Strong Buy).
SNBC: 22.44 (+0.02), TBNK: 27.80 (-0.08), BHBK: 14.26 (+0.01)

Farmers & Merchants Bancorp reports improved net income for Q2 2015 over Q2 2014
M2 - Thu Jul 30, 3:00AM CDT
Farmers & Merchants Bancorp Inc (OTCQX:FMAO) on Wednesday reported net income of USD2.59 or USD0.56 per basic and diluted share for the 2015 second quarter, a 1.7% increase compared to USD2.55m or USD0.55 per basic and diluted share for the same period last year.

Farmers & Merchants Bancorp Reports 2015 Second-Quarter and First-Half Financial Results
PR Newswire - Wed Jul 29, 4:42PM CDT
Farmers & Merchants Bancorp, Inc. (OTCQX: FMAO) today reported financial results for the 2015 second quarter and first half ended June 30, 2015.

Farmers & Merchants Bancorp, Inc. Declares 2nd Quarter Dividend
PR Newswire - Fri Jun 19, 12:50PM CDT
The Board of Directors of Farmers & Merchants Bancorp, Inc., (OTCQX / FMAO) the holding company of The Farmers & Merchants State Bank, with assets of approximately $950 million, at their regular meeting on Friday, June 19, 2015 declared a second quarter dividend of twenty-two cents ($0.22) per share, which reflects an increase from prior quarters. The second quarter dividend is payable on July 20, 2015 to shareholders of record date as of June 30, 2015.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Viking Ventures: Impacts of VK2735 on Obesity Examined

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

CVS Study: GLP-1 Drugs Effective But Costly

By Hannah Lewis Updated Nov 15, 2026 Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

D-Wave Quantum Hit with Securities Fraud Lawsuit

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

IDEAYA's IDE101: A New Front in Cancer Battle

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....